A detailed history of Wealth Architects, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Architects, LLC holds 1,696 shares of AMGN stock, worth $479,747. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,696
Previous 1,902 10.83%
Holding current value
$479,747
Previous $594,000 8.08%
% of portfolio
0.06%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $63,732 - $69,500
-206 Reduced 10.83%
1,696 $546,000
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $32,055 - $38,955
-122 Reduced 6.03%
1,902 $594,000
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $36,297 - $43,815
-135 Reduced 6.25%
2,024 $575,000
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $56,509 - $63,749
-221 Reduced 9.29%
2,159 $621,000
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $32,797 - $40,719
150 Added 6.73%
2,380 $639,000
Q2 2023

Aug 02, 2023

SELL
$214.27 - $253.37 $6,856 - $8,107
-32 Reduced 1.41%
2,230 $495,000
Q1 2023

Apr 21, 2023

SELL
$225.79 - $275.2 $23,707 - $28,896
-105 Reduced 4.44%
2,262 $546,000
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $12,825 - $16,296
56 Added 2.42%
2,367 $621,000
Q3 2022

Oct 24, 2022

BUY
$224.46 - $253.15 $13,916 - $15,695
62 Added 2.76%
2,311 $521,000
Q2 2022

Jul 29, 2022

SELL
$230.71 - $256.74 $43,834 - $48,780
-190 Reduced 7.79%
2,249 $547,000
Q1 2022

May 17, 2022

BUY
$219.27 - $242.57 $58,106 - $64,281
265 Added 12.19%
2,439 $590,000
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $12,330 - $14,111
-62 Reduced 2.77%
2,174 $489,000
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $1,273 - $1,492
6 Added 0.27%
2,236 $475,000
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $12,379 - $13,734
-53 Reduced 2.32%
2,230 $544,000
Q1 2021

Apr 29, 2021

SELL
$221.91 - $258.6 $8,432 - $9,826
-38 Reduced 1.64%
2,283 $568,000
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $2,596 - $3,092
12 Added 0.52%
2,321 $534,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $36,370 - $40,447
155 Added 7.2%
2,309 $587,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $9,099 - $11,166
-46 Reduced 2.09%
2,154 $508,000
Q1 2020

Apr 23, 2020

BUY
$182.24 - $241.7 $8,565 - $11,359
47 Added 2.18%
2,200 $446,000
Q4 2019

Jan 28, 2020

BUY
$189.21 - $243.2 $12,677 - $16,294
67 Added 3.21%
2,153 $519,000
Q3 2019

Oct 23, 2019

SELL
$174.11 - $208.62 $1,044 - $1,251
-6 Reduced 0.29%
2,086 $404,000
Q2 2019

Jul 12, 2019

BUY
$166.7 - $195.41 $11,002 - $12,897
66 Added 3.26%
2,092 $386,000
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $11,213 - $12,640
62 Added 3.16%
2,026 $385,000
Q4 2018

Jan 17, 2019

SELL
$178.4 - $208.25 $5,530 - $6,455
-31 Reduced 1.55%
1,964 $382,000
Q3 2018

Oct 04, 2018

SELL
$185.29 - $208.89 $18,343 - $20,680
-99 Reduced 4.73%
1,995 $414,000
Q2 2018

Jul 19, 2018

BUY
$166.05 - $186.51 $18,763 - $21,075
113 Added 5.7%
2,094 $387,000
Q1 2018

Apr 13, 2018

SELL
$169.43 - $198.0 $16,943 - $19,800
-100 Reduced 4.81%
1,981 $338,000
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $348,130 - $397,471
2,081
2,081 $388,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wealth Architects, LLC Portfolio

Follow Wealth Architects, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.